Danny Nguyen

13PUBLICATIONS

129CO-AUTHORS

Molecular targetsAutonomic nervous systemGene and molecular therapyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|May 13, 2026

BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR Mutations.

|Dec 22, 2025

CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (<i>NRG1</i>) Fusions.

Tejas Patil, Jessica J Lin, Parneet K Cheema

|Jun 21, 2025

Dermatologic Adverse Event Mitigation and Management Strategies with Amivantamab + Lazertinib Therapy for Advanced Non-Small Cell Lung Cancer: A Vodcast.

Danny Nguyen, Edgardo S Santos

|Jun 01, 2025

Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy With or Without Amivantamab.

Zofia Piotrowska, Antonio Passaro, Danny Nguyen

|Jan 29, 2025

First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With <i>EGFR</i> Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial.

Pasi A Jänne, Bin-Chao Wang, Byoung Chul Cho

|Jan 17, 2025

Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial.

Alicia F C Okines, Giuseppe Curigliano, Nobumasa Mizuno

Pageof 3

Frequent Collaborators

Alexander I Spira

James Chih-Hsin Yang

Zofia Piotrowska

Joel W Neal

Nobumasa Mizuno

Ross A Soo

Yoshiaki Nakamura

Helena Alexandra Yu

Victor Ho-Fun Lee

Daniel Shao-Weng Tan

Frequent Collaborators

Alexander I Spira

James Chih-Hsin Yang

Zofia Piotrowska

Joel W Neal